Page 1 | Search Results | Hematology, ASH Education Program

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Indolent lymphomas: pushing the pace with novel agents

Caron A. Jacobson

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 279–286.

https://doi.org/10.1182/hematology.2019000032

Published: 2019

Journal Articles

Novel agents in chronic lymphocytic leukemia

Nicole Lamanna, Susan O’Brien

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 137–145.

https://doi.org/10.1182/asheducation-2016.1.137

Published: 2016

Journal Articles

Patterns of resistance to B cell–receptor pathway antagonists in chronic lymphocytic leukemia and strategies for management

Jennifer A. Woyach

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 355–360.

https://doi.org/10.1182/asheducation-2015.1.355

Published: 2015

Journal Articles

Novel therapy for Hodgkin lymphoma

Connie Lee Batlevi, Anas Younes

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 394–399.

https://doi.org/10.1182/asheducation-2013.1.394

Published: 2013

Journal Articles

Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?

Stefan N. Constantinescu, William Vainchenker

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 553–560.

https://doi.org/10.1182/asheducation.V2012.1.553.3800163

Published: 2012

Journal Articles

Novel Small Molecule Therapeutics for Sickle Cell Disease: Nitric Oxide, Carbon Monoxide, Nitrite, and Apolipoprotein A-I

Gregory J. Kato

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 186–192.

https://doi.org/10.1182/asheducation-2008.1.186

Published: 2008

Journal Articles

Targeting the IAP Family of Caspase Inhibitors as an Emerging Therapeutic Strategy

Aaron D. Schimmer, Shadi Dalili

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 215–219.

https://doi.org/10.1182/asheducation.V2005.1.215.215

Published: 2005

Journal Articles

Modulating the Bcl-2 Family of Apoptosis Suppressors for Potential Therapeutic Benefit in Cancer

Gordon C. Shore, Jean Viallet

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 226–230.

https://doi.org/10.1182/asheducation-2005.1.226

Published: 2005

NARROW

Indolent lymphomas: pushing the pace with novel agents

Novel agents in chronic lymphocytic leukemia

Patterns of resistance to B cell–receptor pathway antagonists in chronic lymphocytic leukemia and strategies for management

Novel therapy for Hodgkin lymphoma

Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?

Novel Small Molecule Therapeutics for Sickle Cell Disease: Nitric Oxide, Carbon Monoxide, Nitrite, and Apolipoprotein A-I

Targeting the IAP Family of Caspase Inhibitors as an Emerging Therapeutic Strategy

Modulating the Bcl-2 Family of Apoptosis Suppressors for Potential Therapeutic Benefit in Cancer

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only